| Product Code: ETC13363390 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Opioid Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Opioid Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Opioid Market Revenues & Volume, 2021 & 2031F |
3.3 North America Opioid Market - Industry Life Cycle |
3.4 North America Opioid Market - Porter's Five Forces |
3.5 North America Opioid Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Opioid Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.7 North America Opioid Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 North America Opioid Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 North America Opioid Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 North America Opioid Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Opioid Market Trends |
6 North America Opioid Market, 2021 - 2031 |
6.1 North America Opioid Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Opioid Market, Revenues & Volume, By Natural Opioids, 2021 - 2031 |
6.1.3 North America Opioid Market, Revenues & Volume, By Semi-Synthetic Opioids, 2021 - 2031 |
6.1.4 North America Opioid Market, Revenues & Volume, By Synthetic Opioids, 2021 - 2031 |
6.1.5 North America Opioid Market, Revenues & Volume, By Combination Formulations, 2020 - 2028 |
6.2 North America Opioid Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Opioid Market, Revenues & Volume, By Pain Management, 2021 - 2031 |
6.2.3 North America Opioid Market, Revenues & Volume, By Anesthesia, 2021 - 2031 |
6.2.4 North America Opioid Market, Revenues & Volume, By Cough Suppression, 2021 - 2031 |
6.2.5 North America Opioid Market, Revenues & Volume, By Opioid Dependence Treatment, 2021 - 2031 |
6.3 North America Opioid Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Opioid Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 North America Opioid Market, Revenues & Volume, By Retail Pharmacies, 2021 - 2031 |
6.3.4 North America Opioid Market, Revenues & Volume, By Online Pharmacies, 2021 - 2031 |
6.3.5 North America Opioid Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.4 North America Opioid Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.2 North America Opioid Market, Revenues & Volume, By Chronic Pain Patients, 2021 - 2031 |
6.4.3 North America Opioid Market, Revenues & Volume, By Surgical Patients, 2021 - 2031 |
6.4.4 North America Opioid Market, Revenues & Volume, By Cancer Patients, 2020 - 2028 |
6.4.5 North America Opioid Market, Revenues & Volume, By Rehabilitation Centers, 2020 - 2028 |
7 North America Opioid Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Opioid Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.2.1 United States (US) Opioid Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.2.2 Canada Opioid Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.2.3 Rest of North America Opioid Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.3 North America Opioid Market Revenues & Volume Share, By Application, 2021 & 2031F |
7.3.1 United States (US) Opioid Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.2 Canada Opioid Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.3 Rest of North America Opioid Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4 North America Opioid Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.4.1 United States (US) Opioid Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.4.2 Canada Opioid Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.4.3 Rest of North America Opioid Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5 North America Opioid Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.1 United States (US) Opioid Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.2 Canada Opioid Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.3 Rest of North America Opioid Market, Revenues & Volume, By End User, 2021 - 2031 |
8 North America Opioid Market Key Performance Indicators |
9 North America Opioid Market - Export/Import By Countries Assessment |
10 North America Opioid Market - Opportunity Assessment |
10.1 North America Opioid Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Opioid Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
10.3 North America Opioid Market Opportunity Assessment, By Application, 2021 & 2031F |
10.4 North America Opioid Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10.5 North America Opioid Market Opportunity Assessment, By End User, 2021 & 2031F |
11 North America Opioid Market - Competitive Landscape |
11.1 North America Opioid Market Revenue Share, By Companies, 2022 |
11.2 North America Opioid Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here